Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss

Transactions of the American Ophthalmological Society

Volumn 107, Issue , 2009, Pages 28-33

  Stepien, Kimberly E ^a   Han, Dennis P ^a   Schell, Jonathan ^a   Godara, Pooja ^a   Rha, Jungtae ^a   Carroll, Joseph ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE;

ADAPTIVE OPTIC IMAGING; ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; EYE EXAMINATION; EYE TOXICITY; FEMALE; HUMAN; IMAGING SYSTEM; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PERIMETRY; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA FOVEA; RETINA TOXICITY; RETINAL TOXICITY; SCOTOMA; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL FIELD; VISUAL IMPAIRMENT;

ANTIRHEUMATIC AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; OPHTHALMOSCOPY; OPTICS AND PHOTONICS; PERIMETRY; RETINA; RETINAL CONE PHOTORECEPTOR CELLS; RETINAL DISEASES; RETINAL PIGMENTS; SJOGREN'S SYNDROME; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL FIELDS;

EID: 77949378551     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mavrikakis I, Sfikakis PP, Mavrikakis E, et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology 2003;110:1321-1326.
2. Bienfang D, Coblyn JS, Liang MH, Corzillius M. Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series. J Rheumatol 2000;27:2703-706.
3. Lai TY, Chan WM, Li H, Lai RY, Lam DS. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol 2005;140:794-807.
4. Lai TY, Ngai JW, Chan WM, Lam DS. Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy. Doc Ophthalmol 2006;112:177-187.
5. Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T. Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum 1997;40:1482-1486.
6. Marmor MF. The dilemma of hydroxychloroquine screening: new information from the multifocal ERG. Am J Ophthalmol 2005;140:894-895.
7. Ruiz RS, Saatci OA. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients. Ann Ophthalmol 1991;23:290-291.
8. Bernstein HN. Ocular safety of hydroxychloroquine. Ann Ophthalmol 1991;23:292-296.
9. Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 2002;109:1377-1382.
10. Marmor MF. New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy. Arthritis Rheum 2003;48:1764.
11. Potsaid B, Gorczynska I, Srinivasan VJ, et al. Ultrahigh speed spectral/Fourier domain OCT ophthalmic imaging at 70,000 to 312,500 axial scans per second. Opt Express 2008;16:15149-15169.
12. Srinivasan VJ, Wojtkowski M, Witkin AJ, et al. High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2006;113:2054.e1-14.
13. Cense B, Chen TC, Nassif N, et al. Ultra-high speed and ultra-high resolution spectral-domain optical coherence tomography and optical Doppler tomography in ophthlamology. Bull Soc Belge Ophtalmol 2006; 123-132.
14. Nassif N, Cense B, Park BH, et al. In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett 2004;29:480-482.
15. Schmidt-Erfurth U, Leitgeb RA, Michels S, et al. Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases. Invest Ophthalmol Vis Sci 2005;46:3393-3402.
16. Wojtkowski M, Srinivasan V, Fujimoto JG, et al. Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2005;112:1734-1746.
17. Carroll J, Neitz M, Hofer H, Neitz J, Williams DR. Functional photoreceptor loss revealed with adaptive optics: an alternate cause of color blindness. Proc Natl Acad Sci U S A 2004;101:8461-8466.
18. Duncan JL, Zhang Y, Gandhi J, et al. High-resolution imaging with adaptive optics in patients with inherited retinal degeneration. Invest Ophthalmol Vis Sci 2007;48:3283-3291.
19. Wolfing JI, Chung M, Carroll J, Roorda A, Williams DR. High-resolution retinal imaging of cone-rod dystrophy. Ophthalmology 2006;113:1014-1019. e1.
20. Roorda A, Williams DR. The arrangement of the three cone classes in the living human eye. Nature 1999;397:520-522.
21. Rha J, Jonnal R, Thorn KE, Qu J, Zhang Y, Miller DT. Adaptive optics flood-illumination camera for high speed retinal imaging. Opt Express 2006;14:4552-4569.
22. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol 1990;292:497-523.
23. Rodriguez-Padilla JA, Hedges TR 3rd, Monson B, et al. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 2007;125:775-780.
24. Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL. Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 1978;17:1158-1175.
25. Bernstein HN, Ginsberg J. The pathology of chloroquine retinopathy. Arch Ophthalmol 1964;71:238-245.
26. Sundelin SP, Terman A. Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells. APMIS 2002;110:481-489.
27. Mahon GJ, Anderson HR, Gardiner TA, McFarlane S, Archer DB, Stitt AW. Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy. Curr Eye Res 2004;28:277-284.
28. Lyons JS, Severns ML. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Am J Ophthalmol 2007;143:801-809.
29. Lyons JS, Severns ML. Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review. Review of mfERG ring ratios in Plaquenil toxicity. Doc Ophthalmol 2009;118:29-36.
30. Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. Retina 2008;28:1478-1486.